comparemela.com

Latest Breaking News On - Carrie mendivil - Page 4 : comparemela.com

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Qatar
Serafim-batzoglou
Weill-cornell
Karsten-suhre
Omid-farokhzad
Patrick-schmidt
Carrie-mendivil
Exchange-commission
Nature-communications
Globenewswire-inc
Seer-inc
Nasdaq

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

REDWOOD CITY, Calif., Feb. 01, 2024 Seer, Inc. , a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results.

Patrick-schmidt
Carrie-mendivil
Nasdaq
Seer-inc
Product-suite
Proteograph-product-suite
Markets

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-francisco
California
United-states
Carrie-mendivil
Seer-inc
Nasdaq
Health-care-conference
Annual-health-care
Annual-health-care-conference
Product-suite
Proteograph-product-suite

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference

REDWOOD CITY, Calif., Dec. 21, 2023 Seer, Inc. , a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating.

San-francisco
California
United-states
Carrie-mendivil
Health-care-conference
Nasdaq
Seer-inc
Annual-health-care-conference
Product-suite
Proteograph-product-suite

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 10, 2023 Seer, Inc. , a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be.

New-york
United-states
Canaccord-medtech
Carrie-mendivil
Services-forum
Seer-inc
Nasdaq
Digital-health
Product-suite
Proteograph-product-suite
Markets

vimarsana © 2020. All Rights Reserved.